RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
RAPID MICRO BIOSYSTEMS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.77+0.01 (+1.20%)
Close on Oct 19, 2026
- Market cap
- $37.40M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.3064 (−74.88%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
RAPID MICRO BIOSYSTEMS, INC. grew revenue 16.1% to $35.18M over the twelve months to Jun 30, 2026. Free cash flow was -$40.39M.
Revenue
$35.18M
+16.1% vs. a year earlier
Operating income
-$49.76M
TTM Q2 2026
Free cash flow
-$40.39M
TTM Q2 2026
EPS, diluted
-$1.12
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $37.40M
- P/E ratio
- –
- Price to sales
- 1.06
- Price to book
- 2.11
- Dividend yield
- –
- Free cash flow yield
- -108.00%
Fundamentals
- Revenue
- $35.18M
- Net income
- -$51.20M
- EPS, diluted
- -$1.12
- Free cash flow
- -$40.39M
- Book value per share
- $0.37
- Diluted shares
- 48M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$35.18M+16.1% YoY
Operating income
-$49.76M
Net income
-$51.20M
EPS, diluted
-$1.12
Free cash flow
-$40.39M
Reported periodTrailing twelve months